ArticleMedical oncology (Northwood, London, England)2014

A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

Qiushi Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.